| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8243150 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 10 Pages |
Abstract
Conclusions:In vivo EPID dosimetry is a viable alternative to pretreatment verification for prostate IMRT. For our patients, combining information from three fractions in vivo is the best way to distinguish systematic errors from non-clinically relevant discrepancies, save hours of quality assurance time per patient plan, and enable verification of the actual patient treatment.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Leah N. B.A./B.Sc.(Hons), Markus Ph.D., Jan-Jakob Ph.D., Marcel Ph.D., Ben J. Ph.D.,